Patent 7358085 was granted and assigned to Sangamo Biosciences Inc. on April, 2008 by the United States Patent and Trademark Office.
Disclosed herein are methods and compositions for treatment of conditions requiring inhibition of angiogenesis. Such conditions include those characterized by neovascularization, such as retinopathies, macular degeneration and various malignancies.